Search clinical trials for: salvage treatment

Total 63732 results

First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Refractory Acute Myeloid Leukemia | Conditioning | Hematopoietic Stem Cell Transplantation | Relapse Leukemia
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate Cancer | Biochemical Recurrence

China
M.D. Anderson Cancer Center
Janssen Scientific Affairs, LLC

Not yet recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Prostate Cancer | Prostatectomy | Androgen Axis Suppression

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Unresectable/Metastatic Colorectal Cancer

China
Swiss Group for Clinical Cancer Research

Recruiting

Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients (salVage)

Non-small Cell Lung Cancer (NSCLC) | Stage IV

Switzerland
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Locally Recurrent Colorectal Cancer

China
French Innovative Leukemia Organisation
Acute Leukemia French Association

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (OGILAR)

AML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
West China Hospital
RemeGen Co., Ltd.

Not yet recruiting

RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

China
Samsung Medical Center

Recruiting

Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer (SALT-LRR)

Breast Cancer

Korea, Republic of
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

Refractory Lymphoma | Relapse | B-cell Non Hodgkin Lymphoma

Italy
The Greater Poland Cancer Centre

Recruiting

Focal Salvage Brachytherapy Study (FocaSaBra) (FocaSaBra)

Prostate Cancer

Poland
Fundacion para la Formacion e Investigacion Sanitarias...

Not yet recruiting

Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent (T3PROJECT)

Peripheral Artery Disease (PAD)
The First Affiliated Hospital of Soochow University
Zhongda Hospital; Suzhou Municipal Hospital; The First People's Hospital of Changzhou

Recruiting

Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL

Acute Lymphoblastic Leukemia

China
M.D. Anderson Cancer Center

Recruiting

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

Multiple Myeloma | Plasma Cell Neoplasm | Malignant Plasma Cell Neoplasm

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment. (MRD-CONFIRM)

Multiple Myeloma

France
Emory University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy

Plasma Cell Myeloma

United States
Stefan Carlsson

Recruiting

Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Prostate Cancer

Sweden
St. Jude Children's Research Hospital
Incyte Corporation; North American Consortium for Histiocytosis; Cures Within...

Recruiting

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis

United States
Grupo Español de Linfomas y Transplante Autólogo...

Recruiting

BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant (BRESELIBET)

Hodgkin Lymphoma, Adult

Spain
Universitaire Ziekenhuizen KU Leuven
Ipsen

Recruiting

Long-term Better Than Short-term ADT With Salvage RT (LOBSTER)

Prostate Cancer

Belgium
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Elucida Oncology

Recruiting

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Prostate Cancer

United States
Deok-Hwan Yang

Not yet recruiting

IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL

Primary Central Nervous System Lymphoma

Korea, Republic of
Ruijin Hospital

Recruiting

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

Esophageal Cancer | Salvage Radiotherapy | Dose-escalation | Mediastinal Lymph Node Recurrence

China
Hospices Civils de Lyon

Recruiting

Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis (EVIDENCE)

Pseudarthrosis

France
Loyola University

Recruiting

BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy (BEACON)

Prostate Cancer - Recurrent

United States
Y-mAbs Therapeutics

Recruiting

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Neuroblastoma

Spain, Denmark, United States, Italy, United Kingdom, Germany, Hong Kong, Canada, France
Samsung Medical Center

Recruiting

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Biliary Tract Cancer

Korea, Republic of
University of Miami

Active, not recruiting

MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial (MAPS)

Prostate Cancer | Prostate Adenocarcinoma

United States
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Withdrawn

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma (FIL_POLARDHAP)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory

Italy
National Cancer Institute (NCI)
NRG Oncology

Completed

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Rectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage II Rectal Cancer AJCC v7

United States, Puerto Rico
RTOG Foundation, Inc.
Pfizer; Astellas Pharma Inc

Active, not recruiting

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery (STEEL)

Prostate Cancer

United States, Canada
University Hospital, Akershus
Sanofi

Terminated

Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer

Testicular Cancer

Denmark, Norway, Italy, Sweden
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Refractory Primary Mediastinal (Thymic)... and other conditions

United States
Yanhong Deng

Completed

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

Rectal Neoplasms | Neuroendocrine Tumors
Sunnybrook Health Sciences Centre
Canadian Association of Radiation Oncology

Active, not recruiting

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Prostate Cancer

Canada
Medical University Innsbruck

Completed

Evaluation of Acute Lower Limb Ischemia (PROMOTE-ALI)

Acute Limb Ischemia

Croatia, United Kingdom, Germany, Austria, France, Hungary, Moldova, Republic of, Netherlands, Serbia, Switzerland
Sun Yat-sen University

Completed

Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Lymphoma, Large B-Cell, Diffuse

China
University Hospital, Ghent

Completed

Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer

Prostate Cancer

Belgium
Tanta University

Completed

Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection

Hepatitis C

Egypt
University Ghent
University Hospital, Geneva

Active, not recruiting

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic Cancer

Norway, Spain, Belgium, Switzerland, Australia, Italy
Nanfang Hospital of Southern Medical University
Shenzhen Second People's Hospital; Peking University Shenzhen Hospital; The Seventh... and other collaborators

Completed

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

Refractory Acute Myeloid Leukemia | Relapsed Acute Erythroid Leukemia | Salvage Treatment | HVA Regimen

China
3M

Completed

SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds

Wounds | Ulcers

United States
Samsung Medical Center

Completed

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Colo-rectal Cancer

Korea, Republic of
Samsung Medical Center

Withdrawn

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Biliary Tract Cancer

Korea, Republic of
Samsung Medical Center

Active, not recruiting

Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study

Colorectal Cancer

Korea, Republic of
Mesoblast, Inc.

Completed

Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients

Graft Versus Host Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Adding New Drugs for HIV Infected Patients Failing Current Therapy

HIV Infections

United States, Puerto Rico
University Hospital Heidelberg
Janssen-Cilag G.m.b.H; National Center for Tumor Diseases, Heidelberg

Terminated

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage (DERANO)

Head and Neck Cancer | Anogenital Cancer

Germany
TaiMed Biologics Inc.
Westat

Completed

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

HIV

United States, Puerto Rico

3

Subscribe